The Food and Drug Administration has given the green light to Vuity 1.25%, the first approved prescription eye drops to treat age-related blurry near vision. Presbyopia, or age-related blurry near ...
Eye drops combining pilocarpine and diclofenac helped patients read extra lines on vision charts, with effects lasting up to two years. The treatment could revolutionize presbyopia care as a safe, non ...
VUITY is the first and only eye drop to treat presbyopia, or age-related blurry near vision, in adults and is FDA-approved for once-daily administration In the VIRGO trial evaluating twice-daily ...
Hosted on MSN
Ditch your glasses - breakthrough eye drops approved by FDA to fix your near vision instantly
In a major medical breakthrough, the U.S. Food and Drug Administration has approved Vizz, a once daily eye drop that helps improve near vision without the need for reading glasses. Created by Lenz ...
Copenhagen, Denmark: Everybody develops presbyopia as they age – a difficulty in focusing on near objects and text – and often have to resort to reading glasses. However, the solution might be as ...
Share on Pinterest Scientists have developed new eye drops that could help with presbyopia. Ekaterina Vasileva-Bagler/Getty Images Researchers estimate that about 1.8 billion people around the world ...
In the United States, around 128 million people live with presbyopia, an age-related condition that causes farsightedness, rendering objects closer to you fuzzy and indistinct. It's fairly common, and ...
Allergan, an AbbVie company, today announced that the Phase 3 VIRGO trial evaluating the safety and efficacy of investigational twice-daily administration of VUITY™ (pilocarpine HCl ophthalmic ...
Please provide your email address to receive an email when new articles are posted on . The study investigated Qlosi’s (pilocarpine hydrochloride ophthalmic solution 0.4%, Orasis Pharmaceuticals) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback